[Ovarian carcinoma: pilot study of hyperthermic intraoperative peritoneal perfusion of antiblastic agents].
Rossi
C R
CR
Dipartimento di Scienze Oncologiche e Chirurgiche, Università di Padova, Italia.
Pilati
P
P
Mocellin
S
S
Vaglini
M
M
Deraco
M
M
Lise
M
M
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery*; D000231:Adenocarcinoma, Papillary / Q000188:drug therapy / Q000601:surgery; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D002945:Cisplatin / Q000008:administration & dosage; D003536:Cystadenocarcinoma / Q000188:drug therapy / Q000601:surgery; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007432:Intraoperative Period; D016685:Mitomycin / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D010529:Peritoneal Cavity; D010865:Pilot Projects; D016019:Survival Analysis; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin; D002945:Cisplatin